Ratings by Barclays (Balaji Prasad)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2025 | Evolus | EOLS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/3/2025 | Pacira Pharmaceuticals | PCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/3/2025 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Tarsus Pharmaceuticals | TARS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2025 | Organon & Co. | OGN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 2/7/2025 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 2/4/2025 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2025 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/27/2025 | Tarsus Pharmaceuticals | TARS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/27/2025 | Evolus | EOLS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/23/2024 | Revance Therapeutic | RVNC | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/12/2024 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 11/12/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/7/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2024 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2024 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2024 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2024 | Revance Therapeutic | RVNC | Downgrade | Equalweight (Overweight) |
6.56 (3.65) |
-44.36% | Details | |
| 9/13/2024 | Revance Therapeutic | RVNC | Downgrade | Equalweight (Overweight) |
6.56 (3.65) |
-44.36% | Details | |
| 9/13/2024 | Evolus | EOLS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2024 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2024 | Alvotech SA | ALVO | Maintain | Overweight (N/A) |
|
Details | ||
| 7/3/2024 | Pacira Pharmaceuticals | PCRX | Downgrade | Equalweight (Overweight) |
28.46 (22.32) |
-21.57% | Details | |
| 6/28/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/5/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/24/2024 | Alvotech SA | ALVO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/23/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 5/21/2024 | Alvotech SA | ALVO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/10/2024 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 5/9/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2024 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/3/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 5/2/2024 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/23/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/22/2024 | Alvotech SA | ALVO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/4/2024 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 2/28/2024 | Tarsus Pharmaceuticals | TARS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/27/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/16/2024 | Organon & Co. | OGN | Maintain | Overweight (N/A) |
|
Details | ||
| 2/14/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/6/2024 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2024 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2024 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2024 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/29/2024 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/29/2024 | Evolus | EOLS | Upgrade | Overweight (Equalweight) |
11.84 (6.03) |
-49.07% | Details | |
| 1/29/2024 | Alvotech SA | ALVO | Upgrade | Overweight (Equalweight) |
14.24 (3.14) |
-77.95% | Details | |
| 1/8/2024 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/8/2024 | Elanco Animal Health | ELAN | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/9/2023 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2023 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2023 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2023 | PolyPid Ltd. | PYPD | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/23/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/23/2023 | Coherus Biosciences | CHRS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/21/2023 | Organon & Co. | OGN | New Coverage | Overweight (N/A) |
19.01 (13.40) |
-29.51% | Details | |
| 9/21/2023 | Alvotech SA | ALVO | New Coverage | Equalweight (N/A) |
9.14 (3.14) |
-65.65% | Details | |
| 8/7/2023 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2023 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 6/23/2023 | Viatris | VTRS | Downgrade | Underweight (Equalweight) |
10.05 (15.56) |
54.83% | Details | |
| 6/1/2023 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/23/2023 | Coherus Biosciences | CHRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/1/2023 | RVL Pharmaceuticals plc | RVLP | Maintain | Overweight (N/A) |
|
Details | ||
| 4/20/2023 | Elanco Animal Health | ELAN | Upgrade | Overweight (Equalweight) |
9.33 (24.57) |
163.34% | Details | |
| 3/10/2023 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/3/2023 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2023 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/22/2023 | Elanco Animal Health | ELAN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/21/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2023 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 2/8/2023 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/21/2022 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 11/16/2022 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2022 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2022 | RVL Pharmaceuticals plc | RVLP | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2022 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 10/25/2022 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2022 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 9/12/2022 | Elanco Animal Health | ELAN | Maintain | Equalweight (N/A) |
|
Details | ||
| 9/12/2022 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/9/2022 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 9/7/2022 | PolyPid Ltd. | PYPD | Downgrade | Equalweight (Overweight) |
1.43 (4.72) |
230.07% | Details | |
| 8/5/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2022 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
15.07 (58.76) |
289.91% | Details | |
| 7/25/2022 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 7/25/2022 | Phibro Animal Health Corp. | PAHC | Downgrade | Underweight (Equalweight) |
19.80 (31.79) |
60.56% | Details | |
| 7/5/2022 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 5/26/2022 | Covetrus | CVET | Downgrade | Equalweight (Overweight) |
19.66 (20.99) |
6.77% | Details | |
| 5/12/2022 | Evolus | EOLS | Upgrade | Equalweight (Underweight) |
11.16 (6.03) |
-45.97% | Details | |
| 5/9/2022 | Endo International plc | ENDP | Maintain | Underweight (N/A) |
|
Details | ||
| 5/9/2022 | Covetrus | CVET | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2022 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/29/2022 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 4/5/2022 | RVL Pharmaceuticals plc | RVLP | New Coverage | Overweight (N/A) |
1.72 (0.03) |
-98.26% | Details | |
| 4/5/2022 | Teva Pharma | TEVA | Upgrade | Overweight (Equalweight) |
9.39 (32.83) |
249.63% | Details | |
| 3/2/2022 | Endo International plc | ENDP | Downgrade | Underweight (Equalweight) |
3.11 (0.29) |
-90.68% | Details | |
| 2/28/2022 | Elanco Animal Health | ELAN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/18/2022 | Teva Pharma | TEVA | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/18/2022 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 1/19/2022 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/10/2022 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/10/2022 | Phibro Animal Health Corp. | PAHC | Upgrade | Equalweight (Underweight) |
20.42 (31.79) |
55.68% | Details | |
| 11/5/2021 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/1/2021 | Dr. Reddy's Laboratories | RDY | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2021 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/1/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/22/2021 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 8/9/2021 | Covetrus | CVET | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2021 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2021 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2021 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/7/2021 | Phibro Animal Health Corp. | PAHC | Downgrade | Underweight (Equalweight) |
29.54 (31.79) |
7.62% | Details | |
| 6/22/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2021 | Evolus | EOLS | Maintain | Underweight (N/A) |
|
Details | ||
| 5/12/2021 | Phibro Animal Health Corp. | PAHC | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/11/2021 | Elanco Animal Health | ELAN | Upgrade | Equalweight (Underweight) |
32.88 (24.57) |
-25.27% | Details | |
| 5/7/2021 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/5/2021 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/4/2021 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2021 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2021 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2021 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2021 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 2/22/2021 | Evolus | EOLS | Maintain | Underweight (N/A) |
|
Details | ||
| 2/17/2021 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
544.08 (560.73) |
3.06% | Details | |
| 2/17/2021 | Covetrus | CVET | New Coverage | Overweight (N/A) |
39.36 (20.99) |
-46.67% | Details | |
| 2/4/2021 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 2/2/2021 | Dr. Reddy's Laboratories | RDY | Upgrade | Overweight (Equalweight) |
61.28 (13.02) |
-78.75% | Details | |
| 12/14/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/14/2020 | Amneal Pharmaceuticals | AMRX | Upgrade | Overweight (Equalweight) |
0.07 (12.88) |
18300% | Details | |
| 11/10/2020 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 11/9/2020 | Elanco Animal Health | ELAN | Downgrade | Underweight (Equalweight) |
32.58 (24.57) |
-24.59% | Details | |
| 11/6/2020 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/30/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/29/2020 | Dr. Reddy's Laboratories | RDY | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/26/2020 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2020 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 10/26/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 9/28/2020 | Revance Therapeutic | RVNC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/18/2020 | AMAG Pharmaceuticals | AMAG | Downgrade | Equalweight (Overweight) |
10.57 (13.75) |
30.09% | Details | |
| 8/12/2020 | Osmotica | OSMT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2020 | Amneal Pharmaceuticals | AMRX | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/10/2020 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2020 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2020 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/4/2020 | Ligand Pharma | LGND | Maintain | Overweight (N/A) |
|
Details | ||
| 7/30/2020 | Dr. Reddy's Laboratories | RDY | Maintain | Equalweight (N/A) |
|
Details | ||
| 7/21/2020 | PolyPid Ltd. | PYPD | New Coverage | Overweight (N/A) |
15.68 (4.72) |
-69.9% | Details | |
| 6/23/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 5/21/2020 | Dr. Reddy's Laboratories | RDY | Maintain | Equalweight (N/A) |
|
Details | ||
| 5/13/2020 | Menlo Therapeutics | MNLO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/13/2020 | Evolus | EOLS | Maintain | Underweight (N/A) |
|
Details | ||
| 5/8/2020 | Teva Pharma | TEVA | Maintain | Underweight (N/A) |
|
Details | ||
| 5/8/2020 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2020 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2020 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 4/7/2020 | Menlo Therapeutics | MNLO | Maintain | Overweight (N/A) |
|
Details | ||
| 4/2/2020 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/25/2020 | Menlo Therapeutics | MNLO | New Coverage | Overweight (N/A) |
3.13 (1.35) |
-56.87% | Details | |
| 2/5/2020 | Phibro Animal Health Corp. | PAHC | Maintain | Equalweight (N/A) |
|
Details | ||
| 1/28/2020 | Phibro Animal Health Corp. | PAHC | Upgrade | Equalweight (Underweight) |
25.31 (31.79) |
25.6% | Details | |
| 12/19/2019 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 12/2/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2019 | Kindred Biosciences | KIN | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2019 | Pacira Pharmaceuticals | PCRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/5/2019 | Evolus | EOLS | Maintain | Underweight (N/A) |
|
Details | ||
| 11/5/2019 | Bausch Health Companies | BHC | Maintain | Overweight (N/A) |
|
Details | ||
| 11/4/2019 | Dr. Reddy's Laboratories | RDY | Maintain | Equalweight (N/A) |
|
Details | ||
| 11/4/2019 | AMAG Pharmaceuticals | AMAG | Maintain | Overweight (N/A) |
|
Details | ||
| 9/23/2019 | Elanco Animal Health | ELAN | New Coverage | Overweight (N/A) |
27.13 (24.57) |
-9.44% | Details | |
| 9/19/2019 | Ligand Pharma | LGND | Upgrade | Overweight (Equalweight) |
98.97 (234.40) |
136.84% | Details | |
| 9/10/2019 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/29/2019 | Phibro Animal Health Corp. | PAHC | Maintain | Underweight (N/A) |
|
Details | ||
| 8/28/2019 | Mallinckrodt plc | MNK | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/12/2019 | Osmotica | OSMT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2019 | Teva Pharma | TEVA | Maintain | Underweight (N/A) |
|
Details | ||
| 8/7/2019 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2019 | Jazz Pharmaceuticals | JAZZ | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2019 | Allergen | AGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/5/2019 | Ligand Pharma | LGND | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/5/2019 | Kindred Biosciences | KIN | Maintain | Overweight (N/A) |
|
Details | ||
| 8/2/2019 | Mylan | MYL | Maintain | Overweight (N/A) |
|
Details | ||
| 6/25/2019 | Allergen | AGN | Upgrade | Equalweight (Underweight) |
129.57 (193.02) |
48.97% | Details | |
| 6/11/2019 | Osmotica | OSMT | New Coverage | Overweight (N/A) |
2.36 (1.11) |
-52.97% | Details | |
| 6/11/2019 | Zoetis Inc. | ZTS | New Coverage | Overweight (N/A) |
110.06 (77.59) |
-29.5% | Details | |
| 6/11/2019 | Phibro Animal Health Corp. | PAHC | New Coverage | Underweight (N/A) |
29.96 (31.79) |
6.11% | Details | |
| 6/11/2019 | Kindred Biosciences | KIN | New Coverage | Overweight (N/A) |
8.01 (9.25) |
15.48% | Details | |
| 6/11/2019 | Teva Pharma | TEVA | New Coverage | Underweight (N/A) |
9.26 (32.83) |
254.54% | Details | |
| 6/11/2019 | Revance Therapeutic | RVNC | New Coverage | Overweight (N/A) |
10.83 (3.65) |
-66.3% | Details | |
| 6/11/2019 | Pacira Pharmaceuticals | PCRX | New Coverage | Overweight (N/A) |
44.24 (28.46) |
-35.67% | Details | |
| 6/11/2019 | Osmotica | OSMT | New Coverage | Overweight (N/A) |
2.36 (1.11) |
-52.97% | Details | |
| 6/11/2019 | Mylan | MYL | New Coverage | Overweight (N/A) |
17.40 (15.86) |
-8.85% | Details | |
| 6/11/2019 | Mallinckrodt plc | MNK | New Coverage | Equalweight (N/A) |
9.29 (0.34) |
-96.34% | Details | |
| 6/11/2019 | Ligand Pharma | LGND | New Coverage | Equalweight (N/A) |
113.56 (98.97) |
-12.85% | Details | |
| 6/11/2019 | Jazz Pharmaceuticals | JAZZ | New Coverage | Overweight (N/A) |
130.97 (188.97) |
44.28% | Details | |
| 6/11/2019 | Foamix Pharmaceuticals | FOMX | New Coverage | Overweight (N/A) |
2.50 (2.99) |
19.6% | Details | |
| 6/11/2019 | Evolus | EOLS | New Coverage | Underweight (N/A) |
14.49 (6.03) |
-58.39% | Details | |
| 6/11/2019 | Endo International plc | ENDP | New Coverage | Equalweight (N/A) |
4.89 (0.29) |
-94.07% | Details | |
| 6/11/2019 | Dr. Reddy's Laboratories | RDY | New Coverage | Equalweight (N/A) |
37.67 (13.02) |
-65.44% | Details | |
| 6/11/2019 | Coherus Biosciences | CHRS | New Coverage | Overweight (N/A) |
17.91 (1.47) |
-91.79% | Details | |
| 6/11/2019 | Bausch Health Companies | BHC | New Coverage | Overweight (N/A) |
21.24 (4.95) |
-76.69% | Details | |
| 6/11/2019 | Amneal Pharmaceuticals | AMRX | New Coverage | Equalweight (N/A) |
7.65 (12.88) |
68.37% | Details | |
| 6/11/2019 | AMAG Pharmaceuticals | AMAG | New Coverage | Overweight (N/A) |
9.69 (13.75) |
41.9% | Details | |
| 6/11/2019 | Allergen | AGN | New Coverage | Underweight (N/A) |
127.13 (129.57) |
1.92% | Details |
